Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Long-Term Investments (2016 - 2025)

Fresenius Medical Care AG (FMS) has 15 years of Long-Term Investments data on record, last reported at $772.5 million in Q4 2025.

  • For Q4 2025, Long-Term Investments changed N/A year-over-year to $772.5 million; the TTM value through Dec 2025 reached $772.5 million, changed N/A, while the annual FY2025 figure was $749.8 million, N/A changed from the prior year.
  • Long-Term Investments reached $772.5 million in Q4 2025 per FMS's latest filing, down from $789.4 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $900.2 million in Q4 2021 and bottomed at $772.5 million in Q4 2025.
  • Average Long-Term Investments over 3 years is $820.7 million, with a median of $789.4 million recorded in 2022.
  • Peak YoY movement for Long-Term Investments: decreased 0.8% in 2021, then decreased 12.31% in 2022.
  • A 3-year view of Long-Term Investments shows it stood at $900.2 million in 2021, then fell by 12.31% to $789.4 million in 2022, then fell by 2.14% to $772.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $772.5 million in Q4 2025, $789.4 million in Q4 2022, and $900.2 million in Q4 2021.